Accelerating Innovation at Leica Biosystems
Year-Over-Year Core Operating Margin Changes
DANAHER CORPORATION
Year Ended December 31, 2017 Operating Profit Margins (GAAP)
Full year 2018 impact from operating profit margins of businesses that have been owned for less than one year or were disposed of during such
period and did not qualify as discontinued operations
Total Company
16.30 %
(0.20)
Incremental year-over-year impact of full year 2018 Dental segment tradename impairments and related restructuring compared to comparable
fourth quarter 2017 charges
Acquisition-related transaction costs deemed significant and fair value adjustments to inventory, in each case related to the acquisition of IDT and
incurred in the second quarter of 2018.
Fourth quarter 2018 Dental segment separation costs
Full
year 2017 impact of restructuring, impairment and related charges related to the discontinuation of a product line in the Diagnostics segment in
the second quarter of 2017
Year-over-year core operating profit margin changes for full year 2018 (defined as all year-over-year operating profit margin changes other
than the changes identified in the lines above) (non-GAAP)
Year Ended December 31, 2018 Operating Profit Margins (GAAP)
0.05
(0.10)
(0.05)
0.40
0.70
17.10 %
Year-over-year core operating profit margin changes (non-GAAP)
Full Year 2020
1.70 %
Full Year 2019
1.00 %
Full Year 2018
0.70 %
Average
2018-2020
1.13 %
Note: The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company's larger acquisitions) if it
determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period. All prior periods presented in the tables above
are the as reported figures from the periods presented. The metrics in the 2018 table above include Envista.
8View entire presentation